191 related articles for article (PubMed ID: 8099818)
21. Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis.
Frossard N; Benabdesselam O; Melac M; Glasser N; Lacronique J; Pauli G
Am J Ther; 1998 Sep; 5(5):307-11. PubMed ID: 10099074
[TBL] [Abstract][Full Text] [Related]
22. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
[TBL] [Abstract][Full Text] [Related]
23. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
Hindmarch I; Johnson S; Meadows R; Kirkpatrick T; Shamsi Z
Curr Med Res Opin; 2001; 17(4):241-55. PubMed ID: 11922397
[TBL] [Abstract][Full Text] [Related]
24. Blood flow in histamine- and allergen-induced weal and flare responses, effects of an H1 antagonist, alpha-adrenoceptor agonist and a topical glucocorticoid.
Hammarlund A; Olsson P; Pipkorn U
Allergy; 1990 Jan; 45(1):64-70. PubMed ID: 2137995
[TBL] [Abstract][Full Text] [Related]
25. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
26. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
Purohit A; Melac M; Pauli G; Frossard N
Br J Clin Pharmacol; 2003 Oct; 56(4):388-94. PubMed ID: 12968983
[TBL] [Abstract][Full Text] [Related]
27. Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl.
Kontou-Fili K; Paleologos G; Herakleous M
Eur J Clin Pharmacol; 1989; 36(6):617-9. PubMed ID: 2570701
[TBL] [Abstract][Full Text] [Related]
28. Compared peripheral H1 inhibiting effects of cetirizine 2 HCl and loratadine.
Rihoux JP; Ghys L; Coulie P
Ann Allergy; 1990 Aug; 65(2):139-42. PubMed ID: 1974399
[TBL] [Abstract][Full Text] [Related]
29. A comparison of central and peripheral effects of cetirizine and loratadine.
Pechadre JC; Beudin P; Eschalier A; Trolese JF; Rihoux JP
J Int Med Res; 1991; 19(4):289-95. PubMed ID: 1680760
[TBL] [Abstract][Full Text] [Related]
30. [Inhibition of histamine-induced wheal, flare and doppler laser flowmetry during long-term (180 days) of cetirizine 10 mg per day treatment].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2005 Dec; 19(114):758-60. PubMed ID: 16521417
[TBL] [Abstract][Full Text] [Related]
31. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
Llupià J; Gras J; Llenas J
Arzneimittelforschung; 2003; 53(2):93-7. PubMed ID: 12642964
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin.
Clough GF; Boutsiouki P; Church MK
Allergy; 2001 Oct; 56(10):985-8. PubMed ID: 11576078
[TBL] [Abstract][Full Text] [Related]
33. The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients.
Chyrek-Borowska S; Siergiejko Z; Michalska I
J Investig Allergol Clin Immunol; 1995; 5(2):103-7. PubMed ID: 7655699
[TBL] [Abstract][Full Text] [Related]
34. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
[TBL] [Abstract][Full Text] [Related]
35. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Purohit A; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
[TBL] [Abstract][Full Text] [Related]
36. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study.
Nielsen PN; Skov PS; Poulsen LK; Schmelz M; Petersen LJ
Clin Exp Allergy; 2001 Sep; 31(9):1378-84. PubMed ID: 11591187
[TBL] [Abstract][Full Text] [Related]
37. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
38. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
[TBL] [Abstract][Full Text] [Related]
39. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524
[TBL] [Abstract][Full Text] [Related]
40. Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.
Maciel-Guerra H; Penha MÁ; Jorge MFS; Libório RDS; Carrijo ACNDA; Parise-Fortes MR; Miot HA
An Bras Dermatol; 2018 Mar; 93(2):233-237. PubMed ID: 29723372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
